57th Annual Denver TB Course (Online Series)

April 02

April 02, 2021, 11:00 am
October 31, 2021, 11:59 pm

- Add to Calendar

View full list of Professional Education courses.

View by:

Since the introduction of effective chemotherapy, many changes have come about in the management of tuberculosis (TB). Most important have been the shift from sanatoria-based to general hospital and clinic-based treatment and the knowledge that active disease can reliably be prevented among those who are latently infected. With the development of effective drugs for TB, the significant advances in bacteriology, and increased knowledge about the treatment of latent TB infection, the approach to tuberculosis control has become increasingly sophisticated.

The 57th Annual Denver TB Course (Online Series) provides a broad overview of active and latent TB including its epidemiology, transmission, pathogenesis, diagnosis, treatment and management. The purpose of this course is to present this body of knowledge to general internists, epidemiologists, preventative medicine, public health, infectious disease and chest specialists, physician assistants, nurse practitioners, registered nurses and other health care providers who will be responsible for the management and care of patients with tuberculosis.

Course Highlights:

Epidemiology of tuberculosis
Transmission and pathogenesis
Diagnosis and treatment of tuberculosis including MDR/XDR-TB
Diagnosis and treatment of latent tuberculosis infection
Emphasis on vulnerable populations such as pediatric and HIV co-infection
Interactive Contact Investigation Workshop

All recorded sessions are now available for purchase and CME/CNE credit through October 31, 2021.

Learning Objectives:

Discuss the epidemiological features which are associated with increased risk for tuberculosis.
Explain the clinical manifestations of tuberculosis and how they differ in unique patient populations such as pediatrics or HIV co-infection.
Recognize the tools available for diagnosis of tuberculosis and their differences, advantages, and possible shortcomings.
Formulate a treatment regimen for a patient with drug susceptible or drug resistant tuberculosis while understanding the pharmacokinetics and potential toxicities of that regimen.
Discuss the importance and performance of contact investigation among persons exposed to new cases of communicable TB.

The 57th Annual TB Course followed a new format in 2021 with weekly virtual presentations being led by expert faculty from April 2 – May 7, 2021. All recorded sessions are now available for purchase and CME/CNE credit through October 31, 2021.

Topics and Speakers:

Presented on Friday, April 2, 2021 These recorded sessions are now available to registrants and for purchase.
	Epidemiology Randall Reves, MD Professor, Infectious Diseases and Epidemiology University of Colorado Denver School of Medicine University of Colorado School of Public Health
	Clinical Presentation and Imaging Shannon Kasperbauer, MD (Program Co-Director) Associate Professor of Medicine Division of Mycobacterial and Respiratory Infections National Jewish Health University of Colorado Health Sciences Center

Presented on Friday, April 9, 2021 These recorded sessions are now available to registrants and for purchase.
	Laboratory Services Reeti Khare, PhD Director, Infectious Disease Laboratory Advanced Diagnostic Laboratories National Jewish Health
	Diagnosis of LTBI Robert Belknap, MD Medical Director, Denver Metro TB Control Program Associate Professor, Division of Infectious Diseases Denver Health and University of Colorado

Presented on Friday, April 16, 2021 These recorded sessions are now available to registrants and for purchase.
	Treatment of Drug Susceptible TB David Griffith, MD Professor of Medicine Division of Mycobacterial and Respiratory Infections National Jewish Health
	Treatment of Drug-Resistant TB Charles Daley, MD (Program Co-Director) Chief, Division of Mycobacterial and Respiratory Infections Professor of Medicine, National Jewish Health University of Colorado Denver

Presented on Friday, April 23, 2021 These recorded sessions are now available to registrants and for purchase.
	Treatment of LTBI Nicholas Walter, MD Associate Professor of Medicine Pulmonary Sciences and Critical Care Medicine University of Colorado
	Monitoring and Management of Side Effects Gwen Huitt, MD Professor of Medicine, Division of Mycobacterial and Respiratory Infections National Jewish Health Associate Professor of Medicine, Division of Infectious Diseases University of Colorado Denver

Presented on Friday, April 30, 2021 These recorded sessions are now available to registrants and for purchase.
	TB and HIV Co-infection Michelle Haas, MD Associate Director, Denver Metro TB Program at Denver Public Health Assistant Professor, Division of Infectious Diseases University of Colorado Anschutz Medical Campus
	Pediatric TB James Gaensbauer, MD Assistant Professor of Pediatrics Section of Pediatrics Infectious Diseases University of Colorado, School of Medicine Pediatric Consultant, Denver Metro Tuberculosis Clinic

Presented on Friday, May 7, 2021 This recorded session is now available to registrants and for purchase.
	Contact Investigation Workshop with Q&A discussion Robert Belknap, MD Medical Director, Denver Metro TB Control Program Associate Professor, Division of Infectious Diseases Denver Health and University of Colorado

Registration Fees:

The following fees include access to all of the recordings of the live sessions through October 31, 2021, as well as CME/CNE credit for courses viewed.

$225 General
$135 Military, Fellow and Resident*
$50 National Jewish Health Staff

* Verification of Fellowship Status Form (required)

To pay now, please fill out the registration form below. To make payment arrangements, please contact ProEd@njhealth.org.

If you are having problems registering, please call 800.844.2305 or 303.398.1000 or email proed@njhealth.org.

Registration is currently closed for this event

Accreditation and Designation Statements

Physicians: National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

National Jewish Health designates this enduring material for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: Provider approved by the California Board of Registered Nursing, Provider Number 12724 for 7.25 contact hours.

Registered nurses will receive a separate certificate for each session of the course. You must view the full session to earn credit; partial credit will not be awarded.